PACB News and Press, Pacific Biosciences of California Inc. From 08/03/22

PacBio Announces Second Quarter 2022 Financial Results PR Newswire MENLO PARK, Calif. , Aug. 3, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2022 . Second quarter results...

Pacific Biosciences has taken a punishment on the chart in FY22, having compressed down more than 86% in 12 months. PACB has de-rated as investors shift focus away from top-line growth stories and move onto bottom-line fundamentals. In that vein, PACB falls behind and valuations a...

Pacific Biosciences of California "PacBio" is a prime candidate for the "Bio Boom" Portfolio in my Compounding Healthcare Seeking Alpha Marketplace Service. I discuss how PACB meets the criteria. PacBio’s HiFi and SMRT sequencing technology continues to fuel growth. The company...

PacBio Announces Appointment of Genomics Industry Veteran Jeff Eidel as Chief Commercial Officer PR Newswire MENLO PARK, Calif. , July 21, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solu...

PacBio to Report Second Quarter 2022 Financial Results on August 3, 2022 PR Newswire MENLO PARK, Calif. , July 18, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 202...

ARK Invest’s 13F portfolio value decreased from $23.96B to $16.91B this quarter. Coinbase Global, Roku, Shopify, and Ginkgo Bioworks were increased while decreasing Spotify, Ionis Pharma, Vertex Pharma, and Sea Limited. The top three positions are Tesla, Zoom Video, and Rok...

Baker Brothers’ 13F portfolio value decreased from $20.55B to $17.40B this quarter. Horizon Therapeutics was increased while decreasing Legend Biotech. The top three positions are Seagen, Incyte Corporation, and BeiGene, and they add up to almost 68% of the portfolio. ...

China is cutting its quarantine time for international travelers to 10 days, which is lending support to sectors like casino stocks. Morgan Stanley just published its Global Exposure Guide, which tracks revenue and cost exposure by region. "While China is a very important source of revenue fo...

CAMBRIDGE, United Kingdom, June 14, 2022 (GLOBE NEWSWIRE) -- Cambridge Epigenetix (CEGX), a life sciences tools and technology company which is revolutionizing genome sequencing, today announced the appointment of Peter J. Fromen as Chief Executive Officer effective July 18, 2022. Gail Marc...

Gainers: O2Micro International Limited (OIIM) +20%. Fluence Energy (FLNC) +7%. Allarity Therapeutics (ALLR) +7%. SIGA Technologies (SIGA) +6%. Blackbaud (BLKB) +5%. Losers: Redbox Entertainment  (RDBX) -10%. Pacific Biosciences of California (PACB) -6%. Jamf Holding  (JAMF...